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I N T R O D U C T I O N
Functional  diversification  of  voltage-gated  potassium 
(KV) channels can be achieved in part through modula-
tion  by  accessory  subunits,  including  the  KCNE  pro-
teins, a family of single transmembrane domain (TMD) 
proteins expressed in the heart, gut, kidney, brain, and 
other tissues (McCrossan and Abbott, 2004; Li et al., 
2006).  Many  KCNE  genes  have  been  associated  with 
various inherited or acquired cardiac arrhythmia syn-
dromes (Abbott and Goldstein, 2002; Melman et al., 
2002; Yang et al., 2004; Ma et al., 2007; Lundby et al., 
2008; Ravn et al., 2008), indicating the physiological 
and pathophysiological importance of this gene family. 
Heterologous  experiments  have  demonstrated  that   
KCNE proteins are promiscuous and can alter the prop-
erties of many KV channels (Abbott and Goldstein, 2002; 
McCrossan and Abbott, 2004; Li et al., 2006). In addi-
tion, certain KV channels such as KCNQ1 (KV7.1) are 
modulated by more than one type of KCNE protein 
with diverse effects (Bendahhou et al., 2005; Lundquist 
et al., 2005), and this specific channel has been adopted 
as an experimental model for elucidating the structural 
requirements and biophysical mechanisms underlying 
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the  effects  of  these  accessory  subunits.  Determining 
how distinct patterns of channel modulation occur has 
important implications for understanding the role of 
KCNE proteins in health and disease.
KCNQ1 is a member of the KV7 voltage-gated K
+ chan-
nel subfamily and, like other KV channels, consists of a 
voltage-sensing domain formed by transmembrane seg-
ments S1–S4 and a pore domain composed of a pore 
loop and S5 and S6 helices. KCNQ1 gating, conductance, 
and pharmacology are radically altered by heterologous 
coexpression with KCNE proteins in vitro. A related KV 
channel, KCNQ4 (KV7.4), is also modulated by KCNE 
proteins but with very different outcomes. Coexpres-
sion of KCNE3 enhances KCNQ1 activity but inhibits 
KCNQ4 function (Schroeder et al., 2000; Strutz-Seebohm 
et al., 2006). Also, KCNE4 inhibits KCNQ1 but does 
not reduce KCNQ4 activity (Grunnet et al., 2002, 2005; 
Strutz-Seebohm et al., 2006). An analysis of divergent 
regions between KCNQ1 and KCNQ4 channels may 
help identify structures required for channel inhibition 
by KCNE4.
Here, we sought to identify primary structure differ-
ences between KCNQ1 and KCNQ4 that account for 
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Modulation of voltage-gated potassium (KV) channels by the KCNE family of single transmembrane proteins has 
physiological and pathophysiological importance. All five KCNE proteins (KCNE1–KCNE5) have been demon-
strated to modulate heterologously expressed KCNQ1 (KV7.1) with diverse effects, making this channel a valuable 
experimental platform for elucidating structure–function relationships and mechanistic differences among mem-
bers of this intriguing group of accessory subunits. Here, we specifically investigated the determinants of KCNQ1 
inhibition by KCNE4, the least well-studied KCNE protein. In CHO-K1 cells, KCNQ1, but not KCNQ4, is strongly 
inhibited by coexpression with KCNE4. By studying KCNQ1-KCNQ4 chimeras, we identified two adjacent residues 
(K326 and T327) within the extracellular end of the KCNQ1 S6 segment that determine inhibition of KCNQ1 by 
KCNE4. This dipeptide motif is distinct from neighboring S6 sequences that enable modulation by KCNE1 and 
KCNE3. Conversely, S6 mutations (S338C and F340C) that alter KCNE1 and KCNE3 effects on KCNQ1 do not ab-
rogate KCNE4 inhibition. Further, KCNQ1-KCNQ4 chimeras that exhibited resistance to the inhibitory effects of 
KCNE4 still interact biochemically with this protein, implying that accessory subunit binding alone is not sufficient 
for channel modulation. These observations indicate that the diverse functional effects observed for KCNE pro-
teins depend, in part, on structures intrinsic to the pore-forming subunit, and that distinct S6 subdomains deter-
mine KCNQ1 responses to KCNE1, KCNE3, and KCNE4.
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Biotechnology, Inc.) or anti-HA antibodies were chemically cross-
linked to protein G Sepharose 4 Fast Flow (GE Healthcare) with 
dimethyl pimelimidate dihydrochloride (Sigma-Aldrich). Mem-
branes were probed with anti-KCNQ1, anti-HA, and anti-GAPDH 
as described previously (Manderfield and George, 2008). Mem-
branes probed with the c-Myc antibody (Covance) were incubated 
overnight with a 1:5,000 dilution of primary antibody and for   
40 min with secondary antibody (1:5,000 dilution; horseradish per-
oxidase–conjugated goat anti–mouse; Santa Cruz Biotechnology, 
Inc.). Under the conditions used, we previously demonstrated 
that no protein–protein interactions occurred during the pro-
cessing of cell lysates or that could be attributed to antibody cross-
reactivity or nonspecific interactions with protein G Sepharose 
(Manderfield and George, 2008; Manderfield et al., 2009).
Coimmunoprecipitation of biotinylated membrane proteins
Cell surface biotinylation of COS-M6 cells was performed in 100-mm 
tissue culture dishes (three per condition), with cells grown to 
70% confluence and transfected as described above. 48 h after 
transfection, the cells were washed twice with ice-cold Dulbecco’s 
PBS (DPBS) supplemented with CaCl2 and MgCl2 (Invitrogen). Af-
ter washing, cells were incubated in 3 ml DPBS plus 0.5 mg × ml
1 
sulfo-NHS-SS-biotin, a cleavable and membrane-impermeant   
biotinylating reagent (Thermo Fisher Scientific) for 1 h on ice 
with shaking. The biotinylation solution was removed and the   
reaction was quenched by washing twice with DPBS with 50 mM 
Tris, pH 8.0, followed by two more washes with DPBS. The cells 
from one dish were lysed with ice-cold RIPA buffer (150 mm NaCl, 
50 mm Tris-Base, pH 7.5, 1% IGEPAL, 0.5% sodium deoxycholate, 
and 0.1% SDS, supplemented with a Complete mini-protease in-
hibitor tablet [Roche]). After cell lysis, the supernatant was trans-
ferred to 1.5-ml microfuge tubes, vortexed for 20 s, rocked for   
30 min at 4°C, and centrifuged at 14,000 g for 30 min. The superna-
tant fraction was collected and retained as the total lysate protein 
fraction.  Samples  were  quantified  using  the  Bradford  reagent 
(Bio-Rad Laboratories), and equal amounts of proteins were used 
in the immunoprecipitation experiments. Aliquots of these su-
pernatants were incubated with protein G Sepharose 4 Fast Flow 
to preclear nonspecific protein binding to the Sepharose beads. 
After this step, the supernatant was incubated with ImmunoPure 
Immobilized Streptavidin beads (Thermo Fisher Scientific) over-
night at 4°C. The samples were centrifuged for 1 min at 14,000 g, 
and the supernatant fraction was collected and retained as the 
nonbiotinylated fraction.
The recovered streptavidin beads were washed with RIPA buf-
fer three times for 5 min at 4°C. Then, the biotinylated proteins 
were eluted with RIPA buffer supplemented with 50 mM DTT for 
2 h at room temperature to cleave the disulfide bond linking the 
covalently attached biotin moiety from streptavidin. The eluted 
sample was diluted to 1 ml with NP-40 buffer. Imunoprecipitation 
with anti-HA was performed as described previously (Manderfield 
and George, 2008). In control experiments, no protein was de-
tected with anti-HA in nonbiotinylated membranes pulled down 
with streptavidin beads. All fractions were then subjected to West-
ern blot analysis as described above, with the exception that all 
membranes were incubated overnight at 4°C with the appropriate 
primary antibody (1:200 anti-KCNQ1, 1:2,000 c-Myc 1:1,000 HA.11, 
or 1:2,000 GAPDH). All secondary antibodies were horseradish 
peroxidase conjugated, diluted to 1:5,000, and incubated at room 
temperature for 40 min. The c-Myc, HA.11, and GAPDH blots 
were probed with goat anti–mouse serum (Santa Cruz Biotech-
nology, Inc.), and KCNQ1[Q4S6]-F4 blots were probed with rabbit 
anti–goat serum (Santa Cruz Biotechnology, Inc.).
Electrophysiology
On the day of the experiment, transfected cells were dissociated 
by brief exposure to trypsin/EDTA, resuspended in supplemented 
their divergent responses to KCNE4. Our work demon-
strated that a subdomain (V324-I328) within the extra-
cellular end of S6 determines the KCNQ1 response to 
KCNE4, and this site is distinct from another S6 region 
that governs KCNQ1 modulation by KCNE1 and KCNE3. 
Further analysis revealed that a dipeptide motif (K326 and 
T327) accounts for the inhibitory response of KCNQ1 
to KCNE4. Our studies also demonstrated that KCNE4 
binding to KCNQ1 is not sufficient for the functional 
effects mediated through the S6 segment.
M AT E R I A L S   A N D   M E T H O D S
Cell culture
Chinese hamster ovary cells (CHO-K1; CRL 9618; American Type 
Culture Collection) were grown in F-12 nutrient mixture medium 
(Invitrogen) supplemented with 10% FBS (ATLANTA Biologicals), 
penicillin (50 U × ml
1), and streptomycin (50 µg × ml
1) at 37°C in 
5% CO2. COS-M6 cells were grown at 37°C in 5% CO2 in Dulbecco’s 
modified Eagle’s medium (Invitrogen) supplemented with 10% 
FBS, penicillin (50 units × ml
1), streptomycin (50 µg × ml
1), and 
20 mm HEPES. Unless otherwise stated, all tissue culture media 
was obtained from Invitrogen.
Plasmids and cell transfection
Full-length human KCNQ1 (GenBank accession no. AF000571), 
KCNQ4 (AF105202), KCNE1 (L28168), and KCNE4 (AY065987) 
cDNAs were generated and engineered in the mammalian ex-
pression vectors pIRES2-EGFP (KCNQ1 and KCNQ4; BD) and a 
modified pIRES2 vector in which we substituted the fluorescent 
protein cDNA with that of DsRed-MST (provided by A. Nagy, Uni-
versity of Toronto, Toronto, Canada; pIRES2-DsRed-MST, KCNE1, 
and  KCNE4)  as  described  previously  (Lundquist  et  al.,  2005; 
Manderfield and George, 2008). Mutations were introduced into 
KCNQ1 and KCNQ4 using the QuikChange Site-Directed Muta-
genesis  system  (Agilent  Technologies).  A  triple  hemagglutinin 
(HA) epitope (YPYDVPDYAGYPYDVPDYAGSYPYDVPDYA) was   
introduced into the KCNE4 cDNA immediately upstream of the 
stop codon as described previously (Manderfield and George, 
2008). The epitope tag does not affect the functional effects of 
KCNE4  or  its  binding  to  KCNQ1  (Manderfield  and  George, 
2008). A c-Myc–tagged KCNQ4 construct (provided by M. Shapiro, 
University of Texas Health Science Center at San Antonio, San 
Antonio, TX; Gamper et al., 2003) was used for detecting KCNQ4–
KCNE4 interactions. All recombinant cDNAs were sequenced in 
their entirety to confirm the presence of the desired modifica-
tions and the absence of unwanted mutations.
Expression of KCNQ and KCNE constructs was achieved by 
transient plasmid transfection using FUGENE-6 (Roche) in which 
2 µg of total cDNA was transfected with a KCNQ-KCNE mass ratio 
of 1:1. When the pore-forming subunit was expressed in the ab-
sence of KCNE subunits, the cells were cotransfected with the 
non-recombinant pIRES2-DsRed-MST vector alone. After trans-
fection, cells were incubated for 48 h as described above before 
use in electrophysiological or biochemical experiments.
Biochemistry
All biochemical experiments including the preparation of cellu-
lar lysates, immunoprecipitation, and Western blotting were com-
pleted as described previously (Manderfield and George, 2008). 
In brief, 48 h after transfection, CHO-K1 cells were lysed with ice-
cold NP-40 buffer (1% NP-40, 150 mM NaCl, and 50 mM Tris, pH 
8.0)  supplemented  with  a  Complete  mini-protease  inhibitor 
(Roche). For immunoprecipitation, anti-KCNQ1 (Santa Cruz   Vanoye et al. 209
Data analysis
Data were collected for each experimental condition from at least 
three transient transfections and analyzed and plotted using a 
combination of Clampfit (MDS Analytical Technologies) and Sig-
maPlot 2000 (Systat Software, Inc.). Statistical analyses were per-
formed using SigmaStat 2.03 (Systat Software, Inc.), and p-values 
are listed in the figure legends. Statistical significance among two 
groups was determined using the unpaired Student’s t test, and 
one-way  ANOVA  followed  by  a  Tukey  post-test  was  performed 
when comparing more than two groups (Fig. 6). Whole cell cur-
rents are normalized for membrane capacitance, and results are 
expressed as mean ± SEM. The number of cells used for each ex-
perimental condition is given in the figure legends.
R E S U LT S
KCNQ1 S6 segment determines inhibition by KCNE4
Previous heterologous expression experiments in Xeno-
pus oocytes demonstrated that KCNE4 inhibits KCNQ1 
(Grunnet et al., 2002, 2005), but not KCNQ4 (Grunnet 
et al., 2002; Strutz-Seebohm et al., 2006). Similarly in 
CHO-K1 cells, transient coexpression of KCNE4 also in-
hibited KCNQ1-induced currents but did not reduce 
whole cell currents in KCNQ4-expressing cells (Fig. 1). 
The distinct responses of KCNQ1 and KCNQ4 moti-
vated our present study using KCNQ1/KCNQ4 chime-
ras to determine the structural requirements for KCNE4 
inhibition of channel activity. Prior studies have suggested 
that the KCNQ1 S6 segment (denoted as KCNQ1-S6) 
F-12 nutrient mixture medium, plated on glass coverslips, and   
allowed to recover for 2 h at 37°C in 5% CO2. Only yellow fluo-
rescent cells (i.e., positive for both EGFP [successful KCNQ   
transfection] and DsRed-MST fluorescence [successful KCNE 
transfection]) were studied. Whole cell currents were recorded at 
room temperature (20–23°C) using Axopatch 200 and 200B am-
plifiers (MDS Analytical Technologies) in the whole cell configu-
ration of the patch clamp technique (Hamill et al., 1981). Pulse 
generation was done with Clampex 8.0 (MDS Analytical Technol-
ogies), and whole cell currents were filtered at 1 kHz and acquired 
at 5 kHz. The access resistance and apparent membrane capaci-
tance were estimated using an established method (Lindau and 
Neher, 1988). Whole cell currents were not leak subtracted. 
Whole cell currents were measured from 80 to +60 mV (in 10-mV 
steps) 1,990 ms after the start of the voltage pulse from a hold-
ing potential of 80 mV. The external solution contained (in 
mM): 132 NaCl, 4.8 KCl, 1.2 MgCl2, 1 CaCl2, 5 glucose, and 10 
HEPES, pH 7.4. And the internal solution contained (in mM): 
110 K
+ aspartate, 1 CaCl2, 10 HEPES, 11 EGTA, 1 MgCl2, and 5 
K2ATP, pH 7.3. Pipette solution was diluted 5–10% to prevent ac-
tivation of swelling-activated currents. Patch pipettes were pulled 
from thick-wall borosilicate glass (World Precision Instruments, 
Inc.) with a multistage P-97 Flaming-Brown micropipette puller 
(Sutter Instrument Co.) and heat polished with a Micro Forge MF 
830 (Narashige). After heat polishing, the resistance of the patch 
pipettes was 3–5 MΩ in the standard extracellular solution. The 
access resistance varied from 3 to 9 MΩ, and experiments were ex-
cluded from analysis if the voltage errors originating from the se-
ries resistance were >5 mV. As a reference electrode, a 2% agar 
bridge with composition similar to the control bath solution was 
used. Junction potentials were zeroed with the filled pipette in 
the bath solution. Unless otherwise stated, all chemicals were ob-
tained from Sigma-Aldrich.
Figure  1.  KCNE4  inhibits 
KCNQ1,  but  not  KCNQ4, 
channels. (A) Representative 
whole cell currents recorded 
from cells cotransfected with 
KCNQ1  plus  either  empty 
plasmid  vector  (left)  or 
KCNE4 (middle). The right 
panel shows the average I-V 
relationship  measured  after 
2-s pulses from cells express-
ing  KCNQ1  alone  ()  and 
KCNQ1  plus  KCNE4  (). 
(B)  Whole  cell  currents  re-
corded  from  cells  cotrans-
fected  with  KCNQ4  plus 
either empty plasmid vector 
(left)  or  KCNE4  (middle). 
The  right  panel  illustrates 
the  average  I-V  relationship 
from cells expressing KCNQ4 
alone () and KCNQ4 plus 
KCNE4 (). Recordings were 
made  from  11–14  cells  for 
each  condition.  p-values  for 
KCNQ1  alone  and  KCNQ1 
plus KCNE4 comparisons are 
<0.005 from 30 to +60 mV. 
In  this  and  subsequent  fig-
ures, the dotted lines in the 
representative traces indicate 
zero current.210 KCNQ1-S6 DETERMINES INHIBITION BY KCNE4
and the TMD of KCNE1 interact functionally or lie   
in close proximity within the assembled channel com-
plex  (Tai  and  Goldstein,  1998;  Tapper  and  George, 
2001; Melman et al., 2004; Panaghie et al., 2006; Kang 
et al., 2008; Chung et al., 2009). Based upon these   
observations, we hypothesized that specific primary 
structure differences between KCNQ1 and KCNQ4 S6 
segments account for the distinct effects of KCNE4 on 
these channels.
To test whether the S6 segment is critical for KCNE4 
inhibition of channel function, a KCNQ1 chimera con-
taining the S6 sequence of KCNQ4 (denoted KCNQ1 
[Q4S6]) was constructed and transiently coexpressed 
with KCNE4 in CHO-K1 cells. The results presented   
in Fig. 2 A indicate that, in contrast to wild-type KCNQ1 
channels,  KCNQ1[Q4S6]  channels  are  not  inhibited   
by  KCNE4.  The  role  of  KCNQ1-S6  in  mediating  the   
response to KCNE4 is supported by the converse chi-
mera in which the S6 segment of KCNQ4 was replaced 
with that of KCNQ1 (KCNQ4[Q1S6]). Unlike wild-type 
KCNQ4,  KCNQ4[Q1S6]  channels  are  inhibited  by 
KCNE4 coexpression (Fig. 2 B). These results supported 
our hypothesis that critical determinants of KCNQ1   
inhibition by KCNE4 reside within the S6 segment   
and can be transferred to KCNQ4 to confer an inhibi-
tory response.
Figure 3.  Divergent residues between KCNQ1 and KCNQ4 S6 
segments.  (A)  Amino  acid  alignment  of  KCNQ1  and  KCNQ4 
S6 segments. The divergent residues are arbitrarily divided into 
three subregions: F4 (V324, K326, T327, and I328), M2 (S330 and 
C331), and L4 (S333, V334, F335, and A336). Asterisks indicate 
amino acid identities between the S6 segments. (B) Spatial loca-
tion of the KCNQ1-S6/KCNQ4-S6 divergent residues in KCNQ1-
S6  is  illustrated  using  a  monomeric  KCNQ1  homology  model 
rendered using CHIMERA software and based upon a previously 
published model (Smith et al., 2007).
Figure  2.  The  KCNQ1-S6 
segment  confers  KCNE4 
sensitivity.  (A)  Representa-
tive whole cell currents and 
I-V  relationships  recorded 
from  cells  coexpressing 
KCNQ1[Q4S6]  with  either 
KCNE4  ()  or  empty  plas-
mid  vector  ().  (B)  Whole 
cell  currents  and  I-V  rela-
tionships recorded from cells 
coexpressing KCNQ4[Q1S6] 
with  either  KCNE4  ()  or 
empty  plasmid  vector  (). 
The  diagrams  above  the 
current  traces  illustrate  the 
chimera  composition:  open 
cylinders  represent  KCNQ1 
transmembrane  segments, 
and gray cylinders represent 
KCNQ4  transmembrane 
segments.  Recordings  were 
made from six to nine cells 
for  each  condition.  p-values 
for  KCNQ1[Q4S6]  alone 
and  KCNQ1[Q4S6]  plus 
KCNE4  comparisons  are 
<0.05 from 10 to 80 mV, 
and ≤0.03 from 0 to +60 mV 
for KCNQ4[Q1S6] alone and 
KCNQ4[Q1S6]  plus  KCNE4 
comparisons.  Vanoye et al. 211
dues were arbitrarily divided into three subregions la-
beled F4 (first four divergent residues), M2 (middle 
two divergent residues), and L4 (last four divergent resi-
dues). To determine which divergent residues between 
KCNQ1 and KCNQ4 S6 segments are critical for inhibi-
tion by KCNE4, KCNQ1 chimeras incorporating each of 
the three divergent subregions from KCNQ4-S6 were 
generated and coexpressed with KCNE4.
Distinct regions of KCNQ1-S6 determine effects  
of KCNE1, KCNE3, and KCNE4
There are 10 residues that differ between the S6 seg-
ments of KCNQ1 and KCNQ4 (Fig. 3 A). In KCNQ1, the 
divergent residues are located between valine-324 (V324) 
and alanine-336 (A336), and their location in the KCNQ1 
channel is depicted in Fig. 3 B using a monomeric KCNQ1 
homology model (Smith et al., 2007). The divergent resi-
Figure  4.  Substitution  of   
lower  and  middle  diver-
gent  regions  of  KCNQ1-S6 
does  not  prevent  KCNE4 
inhibition.  Representative 
whole  cell  current  traces 
and  I-V  relationships  re-
corded  from  cells  express-
ing  KCNQ1[Q4S6]-L4  (A) 
or  KCNQ1[Q4S6]-M2  (B) 
chimeras cotransfected with 
either KCNE4 () or empty 
plasmid vector (). The dia-
grams illustrate the location 
of  the  substituted  residues 
from KCNQ4-S6 (shaded cir-
cles) in the KCNQ1-S6 back-
ground (). Recordings were 
made from six to seven cells 
for  each  condition.  The  p-
values for KCNQ1[Q4S6]-L4 
alone and KCNQ1[Q4S6]-L4 
plus KCNE4 comparisons are 
≤0.006 from 30 to +60 mV, 
and ≤0.007 from 0 to +60 mV 
for KCNQ1[Q4S6]-M2 alone 
and  KCNQ1[Q4S6]-M2  plus 
KCNE4 comparisons.
Figure  5.  The  extracellular 
end  of  KCNQ1-S6  confers 
KCNE4 inhibition. (A) Rep-
resentative  whole  cell  cur-
rent traces and I-V relationships 
recorded from cells expressing 
KCNQ1[Q4S6]-F4 channels 
plus  either  KCNE4  ()  or   
empty  plasmid  vector  ().   
(B)  Whole  cell  current  traces 
and I-V relationships recorded 
from  cells  expressing  KCNQ4 
[Q1S6]-F4 plus either KCNE4 
()  or  empty  plasmid  vector 
(). The diagrams illustrate the 
location of the substituted resi-
dues, with KCNQ1-S6 residues 
shown  as  open  circles  and 
KCNQ4-S6  residues  shown  as 
shaded circles. Recordings were 
made from 10–12 cells for each 
condition. The p-values for 
KCNQ4[Q1S6]-F4 alone and 
KCNQ4[Q1S6]-F4 plus KCNE4 
comparisons  are  ≤0.02  from 
+10 to +60 mV, and ≤0.03 from 
10 to 0 mV.212 KCNQ1-S6 DETERMINES INHIBITION BY KCNE4
acids V324 and I328. This conclusion is strengthened by 
the results obtained with the converse KCNQ4 chimera 
(KCNQ4[Q1S6]-F4)  in  which  only  the  F4  subregion 
residues were replaced with those of KCNQ1. In con-
trast with its effect on wild-type KCNQ4, coexpression 
of KCNE4 significantly reduced KCNQ4[Q1S6]-F4 cur-
rent density (Fig. 5 B), indicating that we can transfer 
inhibitory responsiveness to KCNQ4.
Although substitution of the four most extracellular 
divergent residues in the S6 segment of KCNQ1 (V324-
I328) prevented channel inhibition by KCNE4, these 
substitutions did not generate a completely KCNE- 
insensitive channel. Coexpression of KCNQ1[Q4S6]-F4 
with KCNE1 generated slowly activating currents simi-
lar to those observed when KCNE1 is coexpressed with 
Fig.  4  illustrates  representative  whole  cell  currents   
recorded from CHO-K1 cells transiently expressing 
KCNQ1[Q4S6]-L4  (substitutions  of  S333-A336)  and 
KCNQ1[Q4S6]-M2 (substitutions of S330-C331) in the 
absence  or  presence  of  KCNE4.  Substitution  of  the 
lower (KCNQ1[Q4S6]-L4) and middle (KCNQ1[Q4S6]-
M2) divergent subregions of KCNQ1-S6 with the corre-
sponding amino acids from KCNQ4 did not prevent 
KCNE4 from inhibiting whole cell currents (Fig. 4, A 
and B). In contrast, whole cell currents recorded from 
cells  expressing  KCNQ1[Q4S6]-F4  (substitutions  of 
V324-I328) were not suppressed by KCNE4 (Fig. 5 A). 
These  findings  indicated  that  an  important  determi-
nant of KCNQ1 inhibition by KCNE4 is located within 
the extracellular end of the S6 segment between amino 
Figure 6.  KCNQ1[Q4S6]-F4 channels exhibit 
intact KCNE1 and KCNE3 modulation. Rep-
resentative whole cell currents recorded from 
cells  coexpressing  KCNQ1[Q4S6]-F4  with 
empty vector (A), KCNE1 (B), or KCNE3 (C). 
(D) Average I-V relationships from cells coex-
pressing KCNQ1[Q4S6]-F4 with empty vector 
(; n = 15), KCNE1 (; n = 7), or KCNE3 
(; n = 6). The p-values for KCNQ1[Q4S6]-F4 
alone and KCNQ1[Q4S6]-F4 plus KCNE1 or 
KCNQ1[Q4S6]-F4 plus KCNE3 comparisons are 
≤0.001 from +10 to +60 mV (one-way ANOVA).
Figure  7.  KCNQ1-S338C 
and  KCNQ1-F340C  mutants 
are  inhibited  by  KCNE4.   
(A) Representative whole cell 
currents and I-V relationships 
recorded  from  cells  coex-
pressing KCNQ1-S338C with 
either empty plasmid vector 
(; n = 11), KCNE3 (; n = 6), 
or KCNE4 (; n = 7). The   
p-values for the difference be-
tween  KCNQ1-S338C  alone 
or with KCNE4 coexpression 
are ≤0.01 from 0 to +60 mV. 
(B)  Representative  whole 
cell currents and I-V relation-
ships  recorded  from  cells 
coexpressing  KCNQ1-F340C 
with either empty vector (; 
n = 11), KCNE1 (; n = 6), 
or KCNE4 (; n = 9). The p-
values for the difference be-
tween  KCNQ1-F340C  alone 
or with KCNE4 coexpression 
are ≤0.02 from 0 to +60 mV.  Vanoye et al. 213
The biochemical association of KCNE4 with either 
KCNQ1[Q4S6]-F4 or KCNQ4 in the absence of a func-
tional effect on either channel could indicate that the 
heteromeric complexes do not reach the plasma mem-
brane, and that only homomeric KCNQ1[Q4S6]-F4   
or KCNQ4 channels are present at the cell surface to 
conduct current. To test whether KCNQ1[Q4S6]-F4–
KCNE4  or  KCNQ4–KCNE4  protein  complexes  are 
present at the plasma membrane, we performed coim-
munoprecipitation experiments on biotinylated mem-
brane proteins. These experiments were conducted in 
COS-M6 cells because of the higher protein expression 
needed for sequential protein isolation (i.e., recovery of 
wild-type KCNQ1 (Fig. 6 B) (Barhanin et al., 1996;   
Sanguinetti et al., 1996). Similarly, coexpression of this 
chimera with KCNE3 generated rapidly activating cur-
rents with a linear I-V relationship also resembling the 
effects on wild-type KCNQ1 (Fig. 6 C) (Schroeder et al., 
2000; Melman et al., 2001). These results imply that the 
KCNQ1 S6 segment contains residues critical for the 
channel response to KCNE4, but that these residues are 
distinct from those reported to enable modulation by 
KCNE1 and KCNE3 (Melman et al., 2004; Panaghie   
et al., 2006). We corroborated this observation by testing 
KCNE4 effects on two specific KCNQ1 point mutants, 
KCNQ1-S338C and KCNQ1-F340C, previously shown to 
alter KCNQ1 modulation by KCNE1 and KCNE3, re-
spectively (Melman et al., 2004). Fig. 7 illustrates that 
although these mutant channels exhibit altered sensi-
tivity to KCNE3 (KCNQ1-S338C) and KCNE1 (KCNQ1-
F340C), both were inhibited by KCNE4 coexpression. 
These data provide further support for the hypothesis 
that distinct S6 subdomains influence KCNQ1 responses 
to KCNE1, KCNE3, and KCNE4.
Subunit binding is not sufficient for KCNQ1 inhibition  
by KCNE4
Previous work from our laboratory demonstrated that 
KCNE4 biochemically interacts with KCNQ1 (Manderfield 
and George, 2008). Therefore, a plausible explanation 
for the failure of KCNE4 to modulate KCNQ1[Q4S6]-F4 
is impaired KCNE4 binding to the channel. To test this 
idea, whole cell lysates were obtained from CHO-K1 
cells transiently transfected with HA epitope–tagged 
KCNE4 and either wild-type KCNQ1 or KCNQ1[Q4S6]-F4. 
The lysates were immunoprecipitated with anti-KCNQ1 
and then subjected to SDS-PAGE, followed by Western 
blot analysis to detect KCNQ1 and KCNE4 proteins.   
Fig. 8 A illustrates that KCNE4 can be coimmunoprecipi-
tated with both wild-type KCNQ1 and KCNQ1[Q4S6]-F4. 
These  results  demonstrate  that  the  substitution  of   
the four residues (V324-I328L) in KCNQ1[Q4S6]-F4 
makes the channel resistant to block by KCNE4 but does 
not prevent binding of this accessory subunit to the 
channel. These results indicate that the physical inter-
actions between KCNE4 and KCNQ1 that enable co-
immunoprecipitation are not sufficient to mediate the 
inhibitory effects of KCNE4.
We also examined biochemical interactions between 
KCNE4 and KCNQ4. Whole cell lysates were obtained 
from CHO-K1 cells transiently transfected with HA epi-
tope–tagged KCNE4 and c-Myc epitope–tagged KCNQ4 
(Gamper et al., 2003). The lysates were immunoprecipi-
tated with anti-HA and then subjected to SDS-PAGE, 
followed by Western blot analysis to detect KCNQ4 and 
KCNE4 proteins. Fig. 8 B illustrates that KCNE4 can be 
coimmunoprecipitated with wild-type KCNQ4 despite 
the absence of functional modulation of current car-
ried by these channels (Fig. 1 B).
Figure  8.  Coimmunoprecipitation  of  KCNE4,  KCNQ1(Q4S6)-
F4, and KCNQ4. (A) The top and middle panels illustrate whole 
cell  lysate  proteins  immunoprecipitated  with  an  anti-HA  anti-
body (to recover HA-tagged KCNE4) and then probed with anti-
KCNQ1 antibody (top) or with anti-HA tag antibody (middle). 
NT, nontransfected cells; Q1 + E4, cells transfected with KCNQ1 
and KCNE4-HA; F4 + E4, cells transfected with KCNQ1[Q4S6]-F4 
and KCNE4-HA. (B) The top and middle panels illustrate whole 
cell lysate proteins immunoprecipitated with anti-HA and then 
probed with c-Myc antibody to detect KCNQ4 (top) or with anti-
HA to detect KCNE4 (middle). NT, nontransfected cells; Q4 + 
E4,  cells  transfected  with  c-Myc-KCNQ4  and  KCNE4-HA.  The 
bottom panels in A and B are GAPDH immunoblots of the ini-
tial  whole  cell  lysates  demonstrating  total  protein  expression. 
(C) Biotinylated membrane proteins immunoprecipitated with 
anti-HA and then probed with KCNQ1 antibody (left) to detect 
KCNQ1[Q4S6]-F4 or c-Myc antibody to detect KCNQ4 (right).214 KCNQ1-S6 DETERMINES INHIBITION BY KCNE4
CHO-K1 cells transiently expressing the single mutant 
KCNQ1  channels  KCNQ1-V324L,  KCNQ1-K326R, 
KCNQ1-T327V, or KCNQ1-I328L in the absence or 
presence  of  KCNE4.  All  mutant  channels  generated 
whole cell currents similar to wild-type KCNQ1. Func-
tional analysis of the single mutant KCNQ1 channels 
coexpressed with KCNE4 indicated that the two central 
residues within the F4 subdomain are critical for KCNE4 
inhibition of channel activity. Substitution of either   
lysine 326 by arginine or threonine 327 by valine was 
sufficient  to  disrupt  KCNE4  inhibition  of  KCNQ1.   
As predicted from the results with KCNQ1[Q4S6]-F4 
(Fig. 6 B), coexpression of each single KCNQ1 mutant 
with KCNE1 generated IKs-like currents (not depicted). 
Collectively, these results indicate that the sensitivity of 
KCNQ1 to KCNE4, but not to KCNE1, is determined by 
a dipeptide (lysine-threonine) motif near the extracel-
lular end of KCNQ1-S6.
The relevance of residues K326 and T327 in KCNE4 
sensitivity is underscored by the fact that only KCNQ1 
has these specific amino acids and is the only KV7 chan-
nel inhibited by KCNE4 (Grunnet et al., 2002). In place 
of lysine, the other four KCNQ channels have arginine 
at this position. And instead of threonine, KCNQ4 has 
valine, whereas KCNQ2-3 and KCNQ5 possess leucine 
biotinylated  proteins  with  streptavidin  followed  by   
immunoprecipitation). Fig. 8 C illustrates that KCNQ4 
and KCNQ1[Q4S6]-F4 can be coimmunoprecipitated 
with KCNE4 from membrane protein fractions. Bioti-
nylated protein fractions did not contain intracellular 
proteins based on the observation that GAPDH was only 
detected in the total lysate and nonbiotinylated lanes, 
but not in the biotinylated fraction (not depicted). 
These observations indicate that both KCNQ1[Q4S6]-F4 
and KCNQ4 channels can bind KCNE4 and reach the 
plasma membrane, implying that biochemical interac-
tions between KCNE4 and these channels are not suffi-
cient for the inhibitory effects of this KCNE subunit. 
Moreover, our coimmunoprecipitation results after pro-
tein elution in the presence of 50 mM DTT (see Materials 
and methods) suggest that disulfide bonds are not   
required to maintain the KCNQ1[Q4S6]-F4–KCNE4 or 
KCNQ4–KCNE4 protein complexes.
KCNQ1-S6 dipeptide enables inhibition by KCNE4
To further delimit the region in KCNQ1-S6 critical for 
inhibition  by  KCNE4,  we  individually  substituted  the 
four residues within the F4 region with the correspond-
ing amino acids from KCNQ4. Fig. 9 (A and B) illus-
trates representative whole cell currents recorded from 
Figure 9.  Dipeptide motif unique to KCNQ1-S6 enables KCNE4 inhibition. (A) Representative whole cell currents recorded from cells 
expressing the KCNE4-sensitive mutants KCNQ1-V324L () and KCNQ1-I328L () alone or with KCNE4 and corresponding average 
I-V plots determined in the presence (; n = 6; ; n = 7) or absence (; n = 6 ; ; n = 7) of KCNE4. The p-values are ≤0.013 from 20 to 
+60 mV for KCNQ1-V324L alone compared with KCNQ1-V324L plus KCNE4, and ≤0.001 from 30 to +60 mV for KCNQ1-I328L alone 
compared with KCNQ1-I328L plus KCNE4. (B) Representative whole cell currents recorded from cells expressing the KCNE4-resistant 
mutants KCNQ1-K326R () and KCNQ1-T327V () alone or with KCNE4, and corresponding average I-V plots determined in the pres-
ence (; n = 9; ; n = 7) or absence (; n = 12; ; n = 5) of KCNE4.  Vanoye et al. 215
In this study, we determined that divergent residues 
in the S6 segments of KCNQ1 and KCNQ4 account for 
differences in their responses to KCNE4. These experi-
ments exploited the observations that KCNQ1, but not 
KCNQ4, is strongly inhibited by this accessory subunit 
(Grunnet  et  al.,  2002,  2005;  Strutz-Seebohm  et  al., 
2006). Our findings indicated that a dipeptide sequence 
at the extracellular (outer) end of S6 correlates with the 
distinct  KCNE4  effects  on  KCNQ1  and  KCNQ4.  Al-
though mutations in the outer S6 segment were suffi-
cient to prevent KCNQ1 inhibition by KCNE4, these 
structural changes did not impair biochemical interac-
tions between the two subunits, thus illustrating that ac-
cessory subunit binding alone is not sufficient for the 
inhibitory effects of KCNE4.
We further demonstrated that the outer region of 
KCNQ1-S6 accounts for the dramatic response to KCNE4 
but does not alter KCNQ1 modulation by KCNE1 or 
KCNE3. Previous studies have demonstrated that resi-
dues located toward the cytoplasmic end of KCNQ1-S6 
(S338-F340) are critical for channel modulation by 
KCNE1 and KCNE3 (Melman et al., 2004; Panaghie   
et al., 2006). Our results imply that KCNQ1-S6 contains 
specialized subdomains that separately enable activation 
by KCNE1 and KCNE3 (residues 338–340) or inhibition 
by KCNE4 (residues 326–327).
Mechanistic implications
At  least  two  plausible  mechanisms  involving  either   
gating or permeation can be conceived to explain the   
(Fig.  10  A).  A  helical  wheel  depiction  of  KCNQ1-S6 
(Fig. 10 B) illustrates that the two residues most critical 
for  KCNE4  inhibition  (K326  and  T327,  indicated  by 
solid arrows) are present along a surface-exposed face 
of the helix, whereas the residues (V324 and I328L) 
that do not affect KCNE4 sensitivity reside at the oppo-
site  side  of  the  helix.  The  helical  depiction  of  the 
KCNQ1 S6 segment places K326 and T327 on similar 
faces as F340 and S338 (Fig. 10 B, filled circles), resi-
dues  critical  for  KCNE1  and  KCNE3  modulation  of 
KCNQ1 activity (Melman et al., 2004; Panaghie et al., 
2006). Although the four residues have similar orienta-
tion, K326 and T327 are separated three to four -heli-
cal turns away from F340 and S338.
D I S C U S S I O N
Many important questions remain unanswered regard-
ing the structural determinants and functional mecha-
nisms by which KCNE proteins exert diverse effects   
on KV channels (Abbott et al., 2001; McCrossan and   
Abbott, 2004; Li et al., 2006). Prior work suggests that the 
TMDs of KCNE1, KCNE2, and KCNE3 interact with the 
S1, S4, and S6 segments and the S4–S5 linker of KCNQ1 
to mediate functional effects (Tai and Goldstein, 1998; 
Tapper and George, 2001; Melman et al., 2004; Panaghie 
et al., 2006; Kang et al., 2008; Restier et al., 2008; Shamgar 
et al., 2008; Xu et al., 2008; Chung et al., 2009). In contrast, 
no information exists regarding structures required for 
KCNQ1 inhibition by KCNE4.
Figure  10.  Location  of  K326  and 
T327 in a KCNQ1-KCNE1 closed-state 
model. (A) Amino acid alignment of 
S6 segments from all KCNQ channels 
with  the  divergent  F4  subregion  de-
noted with a shaded box. Asterisks in-
dicate  amino  acid  identities  between 
S6 segments. (B) Helical wheel depic-
tion  of  KCNQ1-S6  with  the  two  resi-
dues  critical  for  KCNE4  modulation 
(K326 and T327) marked with arrows; 
the two residues critical for KCNE1 and 
KCNE3  modulation  (S338  and  F340) 
are marked with filled circles. The heli-
cal wheel representation of KCNQ1-S6 
was  produced  using  HeliQuest  soft-
ware  (http://heliquest.ipmc.cnrs.fr/). 
(C) Side and top views of the KCNQ1 
channel and the KCNE1 TMD (orange 
ribbon). The S1–S5 segments for each 
KCNQ1 monomer are shown with gray 
ribbons, whereas the S6 segments are 
shown in a different color for each sub-
unit. The K326 and T327 residues are 
shown  as  space-filled  molecules.  The 
KCNQ1-KCNE1 closed-state model was 
rendered  using  CHIMERA  software 
and based upon a previously published 
model (Kang et al., 2008).216 KCNQ1-S6 DETERMINES INHIBITION BY KCNE4
linker, and/or by altering channel conductance by in-
teracting with S6 and nearby structures associated with 
the selectivity filter. This model is consistent with the re-
quirement by KCNE1 and KCNE4 for their respective 
C-terminal domains to modulate KCNQ1 and the lack 
of sufficiency of the KCNE1 and KCNE4 C termini alone 
for KCNQ1 modulation (Manderfield et al., 2009). In 
the case of KCNE3, interactions with KCNQ1 may be 
mediated predominantly by the TMD, as supported by 
the observation that removal of the KCNE3 C terminus 
does not greatly perturb the ability of this subunit to 
modulate KCNQ1 (Gage and Kobertz, 2004).
Our variable tethering model is also consistent with 
the idea that a specific KCNE TMD may behave differ-
ently depending on how it is anchored to the rest of the 
channel by the KCNE C terminus. This notion is illus-
trated  by  KCNE1  and  KCNE3  chimeras  carrying  the 
KCNE4 C terminus, which act to inhibit rather than ac-
tivate  KCNQ1  (Manderfield  et  al.,  2009),  suggesting 
that the KCNE4 C terminus is able to impose a KCNE4-
like interaction between KCNQ1 and the TMD of either 
KCNE1 or KCNE3.
In summary, our results provide evidence of a dipep-
tide motif in KCNQ1-S6 that is critical for channel inhi-
bition by KCNE4 and distinct from structures necessary 
for KCNE1 and KCNE3 modulation of the channel. We 
conclude that KV channel functional diversity promoted 
by KCNE subunits depends in part on structures within 
the pore-forming domain.
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